Want to see PETV full AI Analyst Report?
Earnings Data
Report Date
Aug 06, 2026After Close (Confirmed)
Period Ending
2027 (Q1)Consensus EPS Forecast
―Last Year’s EPS
-0.1Same Quarter Last Year
Based on 0 Analysts Ratings
Earnings Call Summary
Q4 2026
Earnings Call Date:Jun 29, 2026|
% Change Since:
|
Earnings Call Sentiment|Neutral
The call conveyed a mix of meaningful strategic and technological progress (AI platform milestones, exclusive AI partnership, Health Canada device recognition, PBM acquisition, strong reductions in liabilities) alongside notable near-term financial challenges (small absolute revenues with only 1% growth, a material gross margin decline driven by low-margin PrecisePRP sales, a $1M impairment, and a $10.5M net loss and cash burn). Operational and product milestones provide a positive long-term narrative, but the company faces short-term execution, profitability, and liquidity risks that balance the positive developments.Company Guidance
Revenue Growth (Modest)
Total revenue increased 1% year-over-year to $1.14 million (FY2026). Distributor sales totaled $886,000 and direct clinic sales totaled $255,000.
Strong Product Validation and Regulatory Milestone
Health Canada officially recognized Spryng with OsteoCushion technology as a veterinary medical device, enabling a planned commercial rollout in Canada (launch preparation for late July).
Major Strategic AI Partnership and New SaaS Platform
Signed an exclusive 10-year white-label licensing agreement with Digital Landia for AgenticPet; launched PetVivo.ai beta (B2B veterinary SaaS) powered by AgenticPet with a commercial launch expected within months.
PetVivo.ai Early Performance Metrics
Beta results show a 50%–90% reduction in veterinary customer acquisition cost (CAC), lowering CAC from a typical $80–$400 to under $43, and the platform is expected to have 80%–90% gross margins and low CapEx scalability.
AI and Tech Milestones
AgenticPet/Ai platform achieved several milestones: 97% diagnostic accuracy reported for AgenticPet, resilient AI infrastructure, proprietary persistent patient memory, smartphone-based diagnostics, and a data monetization framework for anonymized health data.
Strategic Commercial Partnerships and Market Access
Expanded partnership activity — Veterinary Growth Partners (VGP) committed to promote Spryng to its network of more than 7,300 clinics; collaboration with Commonwealth Markets integrating Spryng into top-tier thoroughbred stables.
Acquisition to Expand IP and Pipeline
Announced acquisition of PiezoBioMembrane (PBM), advancing biodegradable piezoelectric biomaterials; Stage B R&D largely complete (scalability and preliminary safety in animals), positioning for accelerated product development and new human/animal applications.
Balance Sheet Improvements
Current liabilities decreased 68% (from $4.3M to $1.4M) and total liabilities decreased 80% (from $5.1M to $1.4M), driven by $1.6M convertible debt conversion, lease termination, vendor settlements, reduced accrued expenses, and extinguished derivative liabilities.
Capital Raise and Working Capital
Raised net proceeds of $877,500 in the final quarter from warrant exercises and equity sales, resulting in working capital of $482,600 as of March 31, 2026.
Marketing and Investor Outreach Momentum
Launched a Tier-1 AI IR marketing program with over 30,000 opted-in contacts and Digital Landia's B2C beta onboarded more than 1,000 active users within 72 hours, indicating strong demand and visibility.
PETV Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
PETV Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Jun 29, 2026 | $0.88 | $0.84 | -4.55% |
Feb 17, 2026 | $0.67 | $0.70 | +3.88% |
Nov 14, 2025 | $1.33 | $1.20 | -9.77% |
Aug 14, 2025 | $0.78 | $0.81 | +3.85% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does PetVivo Holdings (PETV) report earnings?
PetVivo Holdings (PETV) is schdueled to report earning on Aug 06, 2026, After Close (Confirmed).
What is PetVivo Holdings (PETV) earnings time?
PetVivo Holdings (PETV) earnings time is at Aug 06, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is PETV EPS forecast?
Currently, no data Available